Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-2 receptor beta chain inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Celiac Disease 1 D002446 ClinicalTrials
HTLV-I Infections 1 D015490 ClinicalTrials
Leukemia, Large Granular Lymphocytic 1 D054066 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109610